Brian Dorsey is Chief Operating Officer of Silverback Therapeutics, Inc.. Currently has a direct ownership of 6,024 shares of SBTX, which is worth approximately $0. The most recent transaction as insider was on Aug 20, 2024, when has been sold 50,000 shares (Common Stock) at a price of $15.0 per share, resulting in proceeds of $750,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.02K
n/a 3M change
n/a 12M change
Total Value Held $0

Brian Dorsey Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 20 2024
SELL
Open market or private sale
$750,000 $15.0 p/Share
50,000 Reduced 89.25%
6,024 Common Stock
Aug 20 2024
BUY
Exercise of conversion of derivative security
$32,000 $0.64 p/Share
50,000 Added 47.16%
56,024 Common Stock
Aug 13 2024
SELL
Open market or private sale
$390,000 $13.0 p/Share
30,000 Reduced 83.28%
6,024 Common Stock
Aug 13 2024
BUY
Exercise of conversion of derivative security
$19,200 $0.64 p/Share
30,000 Added 45.44%
36,024 Common Stock
BD

Brian Dorsey

Chief Operating Officer
San Diego, CA

Track Institutional and Insider Activities on SBTX

Follow Silverback Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SBTX shares.

Notify only if

Insider Trading

Get notified when an Silverback Therapeutics, Inc. insider buys or sells SBTX shares.

Notify only if

News

Receive news related to Silverback Therapeutics, Inc.

Track Activities on SBTX